Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. [electronic resource]
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology May 2010
- 634-42 p. digital
Aged Aged, 80 and over Anti-Arrhythmia Agents--therapeutic use Atrial Fibrillation--drug therapy Cost of Illness Female Flecainide--therapeutic use Health Surveys Humans Male Middle Aged Prevalence Quality of Life--psychology Self Disclosure Severity of Illness Index Treatment Outcome